F

FimmCyte

4 employees

FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical

Date founded

2022

Funding rounds raised

Total raised

$1M

from 3 investors over 3 rounds

F

FimmCyte raised undisclosed on September 5, 2023

Investors: BioInnovation Institute

F

FimmCyte raised $496K on September 6, 2022

Investors: BioInnovation Institute

F

FimmCyte raised $1M on September 1, 2020

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

FAQ